Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARTEOLOL vs CASPOFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARTEOLOL vs CASPOFUNGIN: Safety Overview

Metric CARTEOLOL CASPOFUNGIN
Total FAERS Reports 318 3,814
Deaths Reported 30 1,419
Death Rate 9.4% 37.2%
Hospitalizations 93 1,638
Average Patient Age 67.5 yrs 47.5 yrs
% Female Patients 56.6% 42.8%
FDA Approval Date Dec 28, 1988 Dec 30, 2016
Manufacturer Sandoz Inc Sandoz Inc
Route OPHTHALMIC INTRAVENOUS
Marketing Status Discontinued Discontinued